COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,803 Articles (22,527 medRxiv, 8,276 bioRxiv)

Most recent first Previous |  Page 2982: Articles 29811-29820  | Next

Projecting the Spread of COVID19 for Germany
Donsimoni, J. R., Glawion, R., Plachter, B., Waelde, K.
10.1101/2020.03.26.20044214 — Posted: 2020-03-30
Disposable N95 Masks Pass Qualitative Fit-Test But Have Decreased Filtration Efficiency after Cobalt-60 Gamma Irradiation
Cramer, A., Tian, E., Yu, S. H., Galanek, M., Lamere, E., Li, J., Gupta, R., Short, M. P.
10.1101/2020.03.28.20043471 — Posted: 2020-03-30 Discussion: Onsite
No SARS-CoV-2 in expressed prostatic secretion of patients with coronavirus disease 2019: a descriptive multicentre study in China
quan, w., zheng, q., tian, j., chen, j., liu, z., chen, x., wu, t., ji, z., tang, j., chu, h., xu, h., zhao, y.
10.1101/2020.03.26.20044198 — Posted: 2020-03-30
Improved deep learning model for differentiating novel coronavirus pneumonia and influenza pneumonia
Zhou, M., Chen, Y., Wang, D., Xu, Y., Yao, W., Huang, J., Jin, X., Pan, Z., Tan, J., Wang, L., Xia, Y., Zou, L., Xu, X., Wei, J., Guan, M., Feng, J., Zhang, H., Qu, J.
10.1101/2020.03.24.20043117 — Posted: 2020-03-30
China's fight against COVID-19: What we have done and what we should do next?
Cheng, S., Zhao, Y., Kaminga, A. C., Zhang, P., Xu, H.
10.1101/2020.03.28.20046086 — Posted: 2020-03-30
An alternative workflow for molecular detection of SARS-CoV-2 - escape from the NA extraction kit-shortage
Fomsgaard, A. S., Rosenstierne, M. W.
10.1101/2020.03.27.20044495 — Posted: 2020-03-30 Discussion: Onsite
Government Responses Matter: Predicting Covid-19 cases in US under an empirical Bayesian time series framework
Liu, Z., Guo, W.
10.1101/2020.03.28.20044578 — Posted: 2020-03-30
Doubling time tells how effective Covid-19 prevention works
Weon, B. M.
10.1101/2020.03.26.20044644 — Posted: 2020-03-30
Trend Analysis and Forecasting of COVID-19 outbreak in India
Gupta, R., Pal, S. K.
10.1101/2020.03.26.20044511 — Posted: 2020-03-30
Dangers of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence
Sriram, K., Insel, P. A.
10.1101/2020.03.25.20043927 — Posted: 2020-03-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).